Synergistic Antiproliferative Effects of Co-nanoencapsulated Curcumin and Chrysin on MDA-MB-231 Breast Cancer Cells Through Upregulating miR-132 and miR-502c

References

• Maasomi ZJ, Soltanahmadi YP, Dadashpour M, Alipour S, Abolhasani S, and Zarghami N: Synergistic anticancer effects of silibinin and chrysin in T47D breast cancer cells. Asian Pacific J Cancer Prevent 18, 1283, 2017.
   PubMedGoogle Scholar
• Siegel RL, Miller KD, and Jemal A: Cancer statistics, 2018. CA: A Cancer Journal for Clinicians 68, 7–30, 2018.
   PubMed Web of Science ®Google Scholar
• Singh R and Mo YY: Role of microRNAs in breast cancer. Cancer Biol Ther 14, 201–212, 2013.
   Web of Science ®Google Scholar
• Vannini I, Fanini F, and Fabbri M: Emerging roles of microRNAs in cancer. Curr Opin Genet Develop 48, 128–133, 2018.
   PubMed Web of Science ®Google Scholar
• Dadashpour M, Pilehvar-Soltanahmadi Y, Mohammadi SA, Zarghami N, Pourhassan-Moghaddam M, et al.: Watercress-based electrospun nanofibrous scaffolds enhance proliferation and stemness preservation of human adipose-derived stem cells. Artif Cells Nanomed Biotechnol 46, 819–830, 2018.
   PubMed Web of Science ®Google Scholar
• Dadashpour M, Pilehvar-Soltanahmadi Y, Zarghami N, Firouzi-Amandi A, Pourhassan-Moghaddam M, et al.: Emerging importance of phytochemicals in regulation of stem cells fate via signaling pathways. Phytother Res 31, 1651–1668, 2017.
   PubMed Web of Science ®Google Scholar
• Chandra D: Mitochondria as Targets for Phytochemicals in Cancer Prevention and Therapy. New York: Springer; 2016.
   Google Scholar
• Dalasanur Nagaprashantha L, Adhikari R, Singhal J, Chikara S, Awasthi S, et al.: Translational opportunities for broad-spectrum natural phytochemicals and targeted agent combinations in breast cancer. Int J Cancer 142, 658–670, 2018.
   PubMed Web of Science ®Google Scholar
• Amirsaadat S, Pilehvar-Soltanahmadi Y, Zarghami F, Alipour S, Ebrahimnezhad Z, et al.: Silibinin-loaded magnetic nanoparticles inhibit hTERT gene expression and proliferation of lung cancer cells. Artif Cells Nanomed Biotechnol 45, 1649–1656, 2017.
   PubMed Web of Science ®Google Scholar
• Alibakhshi A, Ranjbari J, Pilehvar-Soltanahmadi Y, Nasiri M, Mollazade M, et al.: An update on phytochemicals in molecular target therapy of cancer: potential inhibitory effect on telomerase activity. Curr Med Chem 23, 2380–2393, 2016.
   PubMed Web of Science ®Google Scholar
• Nath NC: Role of phytochemicals in the modulation of miRNA expression in cancer. Food Funct 8, 3432–3442, 2017.
   PubMed Web of Science ®Google Scholar
• Sadeghzadeh H, Pilehvar-Soltanahmadi Y, Akbarzadeh A, Dariushnejad H, Sanjarian F, et al.: The effects of nanoencapsulated curcumin-Fe3O4 on proliferation and hTERT gene expression in lung cancer cells. Anti-Cancer Agents Med Chem (Formerly Current Medicinal Chemistry-Anti-Cancer Agents 17, 1363–1373, 2017.
   PubMed Web of Science ®Google Scholar
• Pirmoradi S, Fathi E, Farahzadi R, Pilehvar-Soltanahmadi Y, and Zarghami N: Curcumin affects adipose tissue-derived mesenchymal stem cell aging through TERT gene expression. Drug Res (Stuttg) 68, 213–221, 2018.
   PubMed Web of Science ®Google Scholar
• Norouzi S, Majeed M, Pirro M, Generali D, and Sahebkar A: Curcumin as an adjunct therapy and microRNA modulator in breast cancer. Current Pharmaceutical Design 24, 171–177, 2017.
   Web of Science ®Google Scholar
• Deldar Y, Pilehvar-Soltanahmadi Y, Dadashpour M, Montazer Saheb S, Rahmati-Yamchi M, et al.: An in vitro examination of the antioxidant, cytoprotective and anti-inflammatory properties of chrysin-loaded nanofibrous mats for potential wound healing applications. Artif Cells Nanomed Biotechnol 46, 706–716, 2018.
   PubMed Web of Science ®Google Scholar
• Kasala ER, Bodduluru LN, Barua CC, and Gogoi R: Chrysin and its emerging role in cancer drug resistance. Chem Biol Interact 236, 7–8, 2015.
   PubMed Web of Science ®Google Scholar
• Anari E, Akbarzadeh A, and Zarghami N: Chrysin-loaded PLGA-PEG nanoparticles designed for enhanced effect on the breast cancer cell line. Artif Cells Nanomed Biotechnol 44, 1410–1416, 2016.
   PubMed Web of Science ®Google Scholar
• Eatemadi A, Daraee H, Aiyelabegan HT, Negahdari B, Rajeian B, et al.: Synthesis and characterization of chrysin-loaded PCL-PEG-PCL nanoparticle and its effect on breast cancer cell line. Biomed Pharmacother 84, 1915–1922, 2016.
   PubMed Web of Science ®Google Scholar
• Kasala ER, Bodduluru LN, Madana RM, V AK, Gogoi R, et al.: Chemopreventive and therapeutic potential of chrysin in cancer: mechanistic perspectives. Toxicol Lett 233, 214–225, 2015.
   PubMed Web of Science ®Google Scholar
• Mohammadian F, Pilehvar-Soltanahmadi Y, Alipour S, Dadashpour M, and Zarghami N: Chrysin Alters microRNAs expression levels in gastric cancer cells: possible molecular mechanism. Drug Res (Stuttg) 67, 509–514, 2017.
   PubMed Web of Science ®Google Scholar
• Momtazi AA, Shahabipour F, Khatibi S, Johnston TP, Pirro M, et al.: Curcumin as a microRNA regulator in cancer: a review. Rev Physiol Biochem Pharmacol, 171, 1–38, 2016.
   Google Scholar
• Mohammadian F, Pilehvar-Soltanahmadi Y, Zarghami F, Akbarzadeh A, and Zarghami N: Upregulation of miR-9 and Let-7a by nanoencapsulated chrysin in gastric cancer cells. Artif Cells Nanomed Biotechnol 45, 1201–1206, 2017.
   PubMed Web of Science ®Google Scholar
• Montazeri M, Pilehvar-Soltanahmadi Y, Mohaghegh M, Panahi A, Khodi S, et al.: Antiproliferative and apoptotic effect of dendrosomal curcumin nanoformulation in P53 mutant and wide-type cancer cell lines. Anticancer Agents Med Chem 17, 662–673, 2017.
   PubMed Web of Science ®Google Scholar
• Farajzadeh R, Zarghami N, Serati-Nouri H, Momeni-Javid Z, Farajzadeh T, et al.: Nano-encapsulated metformin-curcumin in PLGA/PEG inhibits synergistically growth and hTERT gene expression in human breast cancer cells. Artif Cells Nanomed Biotechnol 46, 917–925, 2018.
   PubMed Web of Science ®Google Scholar
• Montazeri M, Sadeghizadeh M, Pilehvar-Soltanahmadi Y, Zarghami F, Khodi S, et al.: Dendrosomal curcumin nanoformulation modulate apoptosis-related genes and protein expression in hepatocarcinoma cell lines. Int J Pharm 509, 244–254, 2016.
   PubMed Web of Science ®Google Scholar
• Pilehvar-Soltanahmadi Y, Dadashpour M, Mohajeri A, Fattahi A, Sheervalilou R, et al.: An overview on application of natural substances incorporated with electrospun nanofibrous scaffolds to development of innovative wound dressings. Mini Rev Med Chem 18, 414–427, 2018.
   PubMed Web of Science ®Google Scholar
• Lotfi-Attari J, Pilehvar-Soltanahmadi Y, Dadashpour M, Alipour S, Farajzadeh R, et al.: Co-delivery of curcumin and chrysin by polymeric nanoparticles inhibit synergistically growth and hTERT gene expression in human colorectal cancer cells. Nutr Cancer 69, 1290–1299, 2017.
   PubMed Web of Science ®Google Scholar
• Jalilzadeh-Tabrizi S, Pilehvar-Soltanahmadi Y, Alizadeh E, Alipour S, Dadashpour M, et al.: A biomimetic emu oil-blended electrospun nanofibrous mat for maintaining stemness of adipose tissue-derived stem cells. Biopreserv Biobanking 16, 66–76, 2018.
   PubMed Web of Science ®Google Scholar
• Nejati-Koshki K, Pilehvar-Soltanahmadi Y, Alizadeh E, Ebrahimi-Kalan A, Mortazavi Y, et al.: Development of Emu oil-loaded PCL/collagen bioactive nanofibers for proliferation and stemness preservation of human adipose-derived stem cells: possible application in regenerative medicine. Drug Dev Ind Pharm 43, 1978–1988, 2017.
   PubMed Web of Science ®Google Scholar
• Farajzadeh R, Zarghami N, Serati-Nouri H, Momeni-Javid Z, Farajzadeh T, et al.: Macrophage repolarization using CD44-targeting hyaluronic acid-polylactide nanoparticles containing curcumin. Artif Cells Nanomed Biotechnol 46, 2013–2021, 2018.
   PubMed Web of Science ®Google Scholar
• Jafari-Gharabaghlou D, Pilehvar-Soltanahmadi Y, Dadashpour M, Mota A, Vafajouy-Jamshidi S, et al.: Combination of metformin and phenformin synergistically inhibits proliferation and hTERT expression in human breast cancer cells. Iranian J Basic Med Sci 21, 1167, 2018.
   PubMed Web of Science ®Google Scholar
• Dadashpour M, Firouzi-Amandi A, Pourhassan-Moghaddam M, Maleki MJ, Soozangar N, et al.: Biomimetic synthesis of silver nanoparticles using Matricaria chamomilla extract and their potential anticancer activity against human lung cancer cells. Mater Sci Eng C Mater Biol Appl 92, 902–912, 2018.
   PubMed Web of Science ®Google Scholar
• Pilehvar-Soltanahmadi Y, Nouri M, Martino MM, Fattahi A, Alizadeh E, et al.: Cytoprotection, proliferation and epidermal differentiation of adipose tissue-derived stem cells on emu oil based electrospun nanofibrous mat. Exp Cell Res 357, 192–201, 2017.
   PubMed Web of Science ®Google Scholar
• Nejati-Koshki K, Mortazavi Y, Pilehvar-Soltanahmadi Y, Sheoran S, and Zarghami N: An update on application of nanotechnology and stem cells in spinal cord injury regeneration. Biomed Pharmacother 90, 85–92, 2017.
   PubMed Web of Science ®Google Scholar
• Firouzi-Amandi A, Dadashpour M, Nouri M, Zarghami N, Serati-Nouri H, et al.: Chrysin-nanoencapsulated PLGA-PEG for macrophage repolarization: Possible application in tissue regeneration. Biomed Pharmacother 105, 773–780, 2018.
   PubMed Web of Science ®Google Scholar
• Javidfar S, Pilehvar-Soltanahmadi Y, Farajzadeh R, Lotfi-Attari J, Shafiei-Irannejad V, et al.: The inhibitory effects of nano-encapsulated metformin on growth and hTERT expression in breast cancer cells. J Drug Deliv Sci Technol 43, 19–26, 2018.
   Web of Science ®Google Scholar
• Mehrabi M, Dounighi NM, Rezayat Sorkhabadi SM, Doroud D, Amani A, et al.: Development and physicochemical, toxicity and immunogenicity assessments of recombinant hepatitis B surface antigen (rHBsAg) entrapped in chitosan and mannosylated chitosan nanoparticles: as a novel vaccine delivery system and adjuvant. Artif Cells Nanomed Biotechnol 46, 230–240, 2018.
   PubMed Web of Science ®Google Scholar
• Xiao B, Si X, Han MK, Viennois E, Zhang M, et al.: Co-delivery of camptothecin and curcumin by cationic polymeric nanoparticles for synergistic colon cancer combination chemotherapy. J Mater Chem B 3, 7724–7733, 2015.
   PubMed Web of Science ®Google Scholar
• Ashton JC: Drug combination studies and their synergy quantification using the Chou–Talalay method. Cancer Res 75, 2400, 2015.
   PubMed Web of Science ®Google Scholar
• Hu S, Xu Y, Meng L, Huang L, and Sun H: Curcumin inhibits proliferation and promotes apoptosis of breast cancer cells. Exp Ther Med 16, 1266–1272, 2018.
   PubMed Web of Science ®Google Scholar
• Khoo BY, Chua SL, and Balaram P: Apoptotic effects of chrysin in human cancer cell lines. Int J Mol Sci 11, 2188–2199, 2010.
   PubMed Web of Science ®Google Scholar
• Mayol L, Serri C, Menale C, Crispi S, Piccolo MT, et al.: Curcumin loaded PLGA–poloxamer blend nanoparticles induce cell cycle arrest in mesothelioma cells. Eur J Pharm Biopharm 93, 37–45, 2015.
   PubMed Web of Science ®Google Scholar
• Laishram S, Moirangthem DS, Borah JC, Pal BC, Suman P, et al.: Chrysin rich Scutellaria discolor Colebr. induces cervical cancer cell death via the induction of cell cycle arrest and caspase-dependent apoptosis. Life Sci 143, 105–113, 2015.
   PubMed Web of Science ®Google Scholar
• Lv Z-D, Liu X-P, Zhao W-J, Dong Q, Li F-N, et al.: Curcumin induces apoptosis in breast cancer cells and inhibits tumor growth in vitro and in vivo. Int J Clin Exp Pathol 7, 2818, 2014.
   PubMed Web of Science ®Google Scholar
• Xu Y, Tong Y, Ying J, Lei Z, Wan L, et al.: Chrysin induces cell growth arrest, apoptosis, and ER stress and inhibits the activation of STAT3 through the generation of ROS in bladder cancer cells. Oncol Lett 15, 9117–9125, 2018.
   PubMed Web of Science ®Google Scholar
• Samarghandian S, Azimi Nezhad M, and Mohammadi G: Role of caspases, Bax and Bcl-2 in chrysin-induced apoptosis in the A549 human lung adenocarcinoma epithelial cells. Anticancer Agents Med Chem 14, 901–909, 2014.
   PubMed Web of Science ®Google Scholar
• Samarghandian S, Afshari JT, and Davoodi S: Chrysin reduces proliferation and induces apoptosis in the human prostate cancer cell line pc-3. Clinics (Sao Paulo) 66, 1073–1079, 2011.
   PubMed Web of Science ®Google Scholar
• Tavakoli F, Jahanban-Esfahlan R, Seidi K, Jabbari M, Behzadi R, et al.: Effects of nano-encapsulated curcumin-chrysin on telomerase, MMPs and TIMPs gene expression in mouse B16F10 melanoma tumour model. Artif Cells Nanomed Biotechnol 46, 75–86, 2018.
   PubMed Web of Science ®Google Scholar
• Srivastava SK, Arora S, Averett C, Singh S, and Singh AP: Modulation of microRNAs by phytochemicals in cancer: underlying mechanisms and translational significance. BioMed Res Int 2015, 848710, 2015.
   PubMed Web of Science ®Google Scholar
• Zhao S-F, Zhang X, Zhang X-J, Shi X-Q, Yu Z-J, et al.: Induction of microRNA-9 mediates cytotoxicity of curcumin against SKOV3 ovarian cancer cells. Asian Pac J Cancer Prev 15, 3363–3368, 2014.
   PubMedGoogle Scholar
• Zhang J, Zhang T, Ti X, Shi J, Wu C, et al.: Curcumin promotes apoptosis in A549/DDP multidrug-resistant human lung adenocarcinoma cells through an miRNA signaling pathway. Biochem Biophys Res Commun 399, 1–6, 2010.
   PubMed Web of Science ®Google Scholar
• Kronski E, Fiori ME, Barbieri O, Astigiano S, Mirisola V, et al.: miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and-2. Mol Oncol 8, 581–595, 2014.
   PubMed Web of Science ®Google Scholar
• Saini S, Arora S, Majid S, Shahryari V, Chen Y, et al.: Curcumin modulates MicroRNA-203–mediated regulation of the Src-Akt axis in bladder cancer. Cancer Prev Res 4, 1698–1709, 2011.
   PubMed Web of Science ®Google Scholar
• Ling H, Fabbri M, and Calin GA: MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov 12, 847, 2013.
   PubMed Web of Science ®Google Scholar
• Roy S, Levi E, Majumdar AP, and Sarkar FH: Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF. J Hematol Oncol 5, 58, 2012.
   PubMed Web of Science ®Google Scholar
• Li X, Xie W, Xie C, Huang C, Zhu J, et al.: Curcumin modulates miR-19/PTEN/AKT/p53 axis to suppress bisphenol A-induced MCF-7 breast cancer cell proliferation. Phytother Res 28, 1553–1560, 2014.
   PubMed Web of Science ®Google Scholar
• Mohammadian F, Pilehvar-Soltanahmadi Y, Mofarrah M, Dastani-Habashi M, and Zarghami N: Down regulation of miR-18a, miR-21 and miR-221 genes in gastric cancer cell line by chrysin-loaded PLGA-PEG nanoparticles. Artif Cells Nanomed Biotechnol 44, 1972–1978, 2016.
   PubMed Web of Science ®Google Scholar
• Mohammadian F, Abhari A, Dariushnejad H, Nikanfar A, Pilehvar-Soltanahmadi Y, et al.: Effects of chrysin-PLGA-PEG nanoparticles on proliferation and gene expression of miRNAs in gastric cancer cell line. Iran J Cancer Prev 9, e4190, 2016.
   PubMed Web of Science ®Google Scholar
• Mohammadian F, Abhari A, Dariushnejad H, Zarghami F, Nikanfar A, et al.: Upregulation of Mir-34a in AGS gastric cancer cells by a PLGA-PEG-PLGA chrysin nano formulation. Asian Pac J Cancer Prev 16, 8259–8263, 2016.
   Google Scholar
• Tahiri A, Leivonen S-K, Lüders T, Steinfeld I, Ragle Aure M, et al.: Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors. Carcinogenesis 35, 76–85, 2014.
   PubMed Web of Science ®Google Scholar
• Zhang Z-G, Chen W-X, Wu Y-H, Liang H-F, and Zhang B-X: MiR-132 prohibits proliferation, invasion, migration, and metastasis in breast cancer by targeting HN1. Biochem Biophys Res Commun 454, 109–114, 2014.
   PubMed Web of Science ®Google Scholar
• Keklikoglou I, Koerner C, Schmidt C, Zhang J, Heckmann D, et al.: MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways. Oncogene 31, 4150, 2012.
   PubMed Web of Science ®Google Scholar
• Meylan E, Dooley AL, Feldser DM, Shen L, Turk E, et al.: Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma . Nature 462, 104, 2009.
   PubMed Web of Science ®Google Scholar
• Singh S, Shi Q, Bailey ST, Palczewski MJ, Pardee AB, et al.: Nuclear factor-κB activation: a molecular therapeutic target for estrogen receptor–negative and epidermal growth factor receptor family receptor–positive human breast cancer. Mol Cancer Ther 6, 1973–1982, 2007.
   PubMed Web of Science ®Google Scholar